Vancouver's BC Cancer Agency manages CML and GIST patients requiring long-term Imatinib therapy. Imatib 400mg provides identical treatment to brand Gleevec at significantly reduced cost for Vancouver patients facing coverage gaps.
Generic Imatib delivers the same BCR-ABL targeting mechanism, converting CML into a manageable chronic condition for most patients who achieve sustained molecular response.
|
FAQ: What side effects are most common when starting
Imatib treatment? The most common early side
effects include nausea, mild fluid retention (especially around the eyes),
muscle cramps, and skin rash. Most of these tend to improve over the first
few months of treatment as the body adjusts. Taking Imatib with food and a
large glass of water can help reduce stomach upset. Persistent or severe side
effects should always be discussed with your oncologist. |
